Context Therapeutics Inc.

NASDAQ: CNTX · Healthcare · Biotechnology

PublicHQ Philadelphia, PA · PhiladelphiaCIK 0001842952Reports USD

#1 of 1,394 Healthcare companies by revenue

EA Score

——

FH 53DQ —GM —SS 36

v0.1 · 35/100 weight · pillars only

↑ balance-sheet leverage, filing timeliness · ↓ listing tenure, Piotroski F

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$36.1M

Employees

Market cap

$60.1M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Net income-$36.1M-$36.1M2025

Operating income-$39.7M-$39.7M2025

Total assets$68.5M$68.5M2025

Liabilities$8.0M$8.0M2025

Equity$60.5M$60.5M2025

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Context Therapeutics Inc. earned -$36.1M in FY2025 net income.

Peers · Healthcare

Xilio Therapeutics, Inc.37D Outlook Therapeutics, Inc.22D Filana Therapeutics, Inc.40D Pulmonx Corporation57C

Neighbors

Philadelphia →

Comcast Corporation$123.7B86A Carpenter Technology Corporation$2.9B81B+Aramark$18.5B64C Five Below, Inc.$4.8B77B+Axalta Coating Systems Ltd.$5.1B78B+Urban Outfitters, Inc.$6.2B72B

Key facts

CEOMartin A. Lehr

SectorHealthcare

IndustryBiotechnology

HeadquartersPhiladelphia, PA

ExchangeNASDAQ: CNTX

Employees15

IPO date2021-10-20

Latest filings

8-K2026-06-26 8-K2026-06-15 8-K2026-05-18 10-Q2026-05-06 8-K2026-05-01 DEF 14A2026-04-28 8-K2026-04-02 8-K2026-03-23

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.